[
    {
        "utterance": "Tom Mansell: Sensing and regulation is a big part of the plan here. But for now, we're in the very preliminary stages of that. ",
        "annotations": {
            "explain or define term or concept": "Tom clarifies the team's current progress on sensing and regulation, defining their status as 'very preliminary stages'.",
            "provide supporting evidence": "Tom supports his statement about the project's stage by stating that they are in the 'very preliminary stages'."
        }
    },
    {
        "utterance": "Tanya Nguyen: To follow up on what you're saying and also what Jay had mentioned earlier, and I have no idea how to do this, but it would be so cool to develop a way to kind of individually determine what someone's microbiome is at homeostasis, their ideal kind of microbiome environment, whether that be composition, metabolites, chemicals, and then use that as a baseline, and then being able to develop, you know, these different chemically engineered bacteria then produce specific metabolites to keep that person at that specific ideal level or attain an ideal level for them to then minimize their clinical symptoms or functioning. I think that would be a really cool idea, no idea how to get there, but happy to talk about it further and develop that. ",
        "annotations": {
            "present new idea": "Tanya describes a novel approach of individually determining a person's ideal microbiome environment and using engineered bacteria to maintain it, minimizing clinical symptoms.",
            "expand on existing idea": "Tanya builds upon the previous discussion of sensing and regulation in the microbiome by suggesting a specific method for personalized intervention.",
            "express enthusiasm": "Tanya expresses excitement about the potential of this idea by saying \"it would be so cool\" and \"a really cool idea\".",
            "acknowledge contribution": "Tanya explicitly refers to and builds upon prior comments made by Tom and Jay."
        }
    },
    {
        "utterance": "Tom Mansell: I think you could do it with one molecule. I don't know about all of those. But you know, if it's short chain fatty acids, I think that that's a great idea. ",
        "annotations": {
            "expand on existing idea": "Tom expands on Tanya's idea of personalized microbiome management by suggesting focusing on a single molecule like short-chain fatty acids.",
            "reject idea": "Tom expresses doubt about managing the entire microbiome but suggests a more feasible approach.",
            "express agreement": "Tom agrees that focusing on short-chain fatty acids is a good idea, supporting Tanya's overall concept."
        }
    },
    {
        "utterance": "Tom Mansell: Right now, I think, in general, the approaches, well, let's just make more, make more given prebiotics, given probiotics that we think are going to make butyrate. But you know, there might, there's probably a level that's too high, right? ",
        "annotations": {
            "expand on existing idea": "Tom expands on the previously mentioned idea of using prebiotics and probiotics by suggesting the approach of simply increasing their production to generate more butyrate.",
            "provide supporting evidence": "Tom supports his idea by mentioning the general approach of using prebiotics and probiotics to produce butyrate.",
            "present new idea": "Tom introduces the idea that there might be an upper limit to the beneficial level of butyrate.",
            "ask clarifying question": "Tom asks for confirmation about the possibility of having too high a level of butyrate by posing the question \"right?\""
        }
    },
    {
        "utterance": "Tom Mansell: Do they take 12 different probiotic supplements every day to maintain that? You know, that's kind of the, yeah, so. ",
        "annotations": {
            "ask clarifying question": "Tom is asking a clarifying question about the practicality and feasibility of maintaining a specific microbiome balance through excessive supplement intake, questioning if individuals consume numerous probiotics daily to achieve this.",
            "express humor": "Tom uses humor to highlight the absurdity of taking 12 different probiotic supplements daily, suggesting it's an impractical approach."
        }
    },
    {
        "utterance": "Tom Mansell: Yeah, no, that's a good idea. I mean, there is this whole, you know, what's a healthy microbiome, what's a healthy metabolome. That's, I think, going to vary by the host, and these host factors really influence these things, right? So, in addition to diet, of course, right? ",
        "annotations": {
            "acknowledge contribution": "Tom acknowledges Tanya's idea by saying \"that's a good idea.\"",
            "expand on existing idea": "Tom expands on the idea of personalized microbiome management by mentioning that a healthy microbiome and metabolome will vary by the host and are influenced by host factors, adding to Tanya's earlier point about individual baselines.",
            "provide supporting evidence": "Tom supports his claim about host factors influencing microbiome health by mentioning diet as an example."
        }
    },
    {
        "utterance": "Tom Mansell: You can blame it on behavior a little bit, but also there's probably genetic factors too, right, that influence your microbiome. I'm just gabbling, yeah. ",
        "annotations": {
            "expand on existing idea": "Tom expands on the idea of factors influencing the microbiome by adding genetic factors to the previously mentioned behavioral factors.",
            "provide supporting evidence": "Tom supports the idea of host factors influencing the microbiome by mentioning genetic factors' impact.",
            "explain or define term or concept": "Tom explains the concept of host factors influencing the microbiome by mentioning genetic factors alongside behavior and diet."
        }
    },
    {
        "utterance": "Jae Sung: I guess we have many more questions than answers. That's because that's how science works. Very interesting. ",
        "annotations": {
            "present new idea": null,
            "expand on existing idea": null,
            "provide supporting evidence": null,
            "explain or define term or concept": null,
            "ask clarifying question": null,
            "propose decision": null,
            "confirm decision": null,
            "express alternative decision": null,
            "express agreement": null,
            "assign task": null,
            "offer constructive criticism": null,
            "reject idea": null,
            "resolve conflict": null,
            "express frustation": null,
            "acknowledge contribution": "Jae Sung acknowledges the earlier contributions by stating there are more questions than answers.",
            "encourage particpation": null,
            "express enthusiasm": "Jae Sung finds the conversation \"very interesting.\"",
            "express humor": null
        }
    },
    {
        "utterance": "Tom Mansell: I just have to say, as a chemical engineer, the thing that I have gotten most out of this discussion is this motility concept, right? And so we talked, you know, Emily framed the discussion as, this is a bioreactor, right? This is, we have a whole core curriculum on this on reactor design. ",
        "annotations": {
            "acknowledge contribution": "Tom acknowledges Emily's contribution to the discussion by mentioning how she framed it.",
            "explain or define term or concept": "Tom explains how he thinks of the gut as a bioreactor and relates it to his background as a chemical engineer and existing curriculum on reactor design."
        }
    },
    {
        "utterance": "Tom Mansell: A key parameter of reactor design is residence time, which is the flow rate divided by the volume, right? So, that motility, being the flow rate, is going to influence the conversion or whatever fermentation products come out of your reactor, right? And so, I love this idea of influencing motility as a way to manipulate the microbiome, and in doing so, manipulate the metabolome. ",
        "annotations": {
            "explain or define term or concept": "Tom defines \"residence time\" as \"flow rate divided by the volume\" in the context of reactor design principles, and explains how motility, as the flow rate, influences the microbiome and metabolome.",
            "expand on existing idea": "Tom expands on the previously introduced bioreactor analogy by explaining how a key parameter, residence time (flow rate/volume), influences the resulting metabolites.",
            "express enthusiasm": "Tom expresses his strong interest in the idea of influencing motility to manipulate the microbiome and metabolome, stating that he \"loves this idea.\""
        }
    },
    {
        "utterance": "Faranak Fattahi: It's circular, and then it affects motility again. ",
        "annotations": {
            "expand on existing idea": "This utterance builds upon the prior discussion of motility and reactor design by pointing out the circular relationship between motility and the microbiome.",
            "provide supporting evidence": "This utterance supports the idea of motility influencing the microbiome by highlighting the feedback loop where changes in the microbiome affect motility."
        }
    },
    {
        "utterance": "Tom Mansell: Right. ",
        "annotations": {
            "confirm decision": "Tom confirms Faranak's statement that \"It's circular, and then it affects motility again\" regarding the influence of motility on the microbiome and metabolome, thus finalizing the point of their discussion."
        }
    },
    {
        "utterance": "Tom Mansell: Yes, of course. And you know, like many processes, it probably is a small disruption that becomes non-linear, and then, you know, that's when you end up in a disease state. I don't know, I'm not that kind of doctor, but ",
        "annotations": {
            "expand on existing idea": "Tom is building on the previous speaker's comment about circularity by adding the idea of a small disruption becoming non-linear and leading to a disease state.",
            "provide supporting evidence": "Tom supports his claim about non-linear disruptions leading to disease states by referencing general knowledge of many processes.",
            "express humor": "Tom uses humor to downplay his medical expertise by saying \"I'm not that kind of doctor\" after discussing disease states."
        }
    },
    {
        "utterance": "Tom Mansell: So, Faranak, I think we should talk about your ENS essay a little more. ",
        "annotations": {
            "assign_task": "Tom assigns Faranak the task of discussing her ENS essay further.",
            "propose_decision": "Tom proposes that he and Faranak discuss her ENS essay."
        }
    },
    {
        "utterance": "Faranak Fattahi: Absolutely. Yeah, I'd love to. So we have actually done a lot of high throughput assays just looking at, you know, a library of neuroactive compounds. So these are around maybe 500 or 600 just small molecules that affect different neurotransmitter receptors. And turns out a lot of neurons in the GI tract respond to a variety of different neurotransmitter agonists and antagonists. And many of them could be influenced by microbial products. ",
        "annotations": {
            "provide supporting evidence": "Faranak supports her interest in discussing the ENS essay by mentioning the high throughput assays conducted on a library of neuroactive compounds and their effects on neurotransmitter receptors in the GI tract.",
            "explain or define term or concept": "Faranak explains the scope of their research by specifying the number of small molecules in the library (500-600) and their impact on neurotransmitter receptors.",
            "express enthusiasm": "Faranak expresses enthusiasm to discuss the ENS essay further with Tom by saying \"Absolutely. Yeah, I'd love to.\""
        }
    },
    {
        "utterance": "Emily Balskus: We probably have five minutes or so left. So, thinking about, it looks like Jay might have stepped away from his computer. Thinking about condensing and highlighting the key takeaways. ",
        "annotations": {
            "propose decision": "Emily suggests focusing on summarizing key discussion points due to time constraints and Jay's absence.",
            "explain or define term or concept": "Emily clarifies the task by specifying \"condensing and highlighting\" the key takeaways."
        }
    },
    {
        "utterance": "Faranak Fattahi: I guess for me, the main takeaways are we have, so the field has identified many interesting correlations between certain fermentation products and neurological disorders. And so we know that those actually are relevant to actual clinical data and in mouse models. And so we are expanding, we are hoping to expand our knowledge of what other products might be important and like overall in our lives. ",
        "annotations": {
            "provide supporting evidence": "Faranak supports the relevance of fermentation products to neurological disorders by citing clinical data and mouse models.",
            "expand on existing idea": "Faranak expands on the discussion of the gut microbiome and its impact on health by focusing on the specific link between fermentation products and neurological disorders.",
            "explain or define term or concept": "Faranak explains the connection between fermentation products from the microbiome and their impact on neurological disorders, clarifying the relevance of prior research."
        }
    },
    {
        "utterance": "Emily Balskus: We really don't have, yeah. ",
        "annotations": {
            "None": "No code from the codebook applies to this short, unclear utterance."
        }
    },
    {
        "utterance": "Faranak Fattahi: And then we want to know if we can build models to then get at the mechanistic steps where basically these, these products then induce all these changes in the body that then translate into effects on the disease. ",
        "annotations": {
            "expand on existing idea": "Faranak is building on the previously discussed correlations between fermentation products and neurological disorders by proposing the development of models to investigate the mechanistic steps involved.",
            "present new idea": "The concept of building models to understand the mechanistic steps between microbial products, bodily changes, and disease effects is a new idea introduced by Faranak.",
            "explain or define term or concept": "Faranak is explaining her research approach by defining the purpose of building models, which is to understand the mechanistic steps involved in the effects of microbial products on disease."
        }
    },
    {
        "utterance": "Faranak Fattahi: I guess another important point was the medications and how they get affected by the microbiome and then vice versa, how like management of these patients affect the motility and the composition of the microbes. ",
        "annotations": {
            "provide_supporting_evidence": "Faranak provides additional points related to the effects of medication on the microbiome and patient management on motility and microbial composition, expanding on the discussion of the microbiome's role in health and disease.",
            "expand_on_existing_idea": "Faranak is building upon the previous discussion by adding the point about medication and patient management's impact on the microbiome and its composition."
        }
    },
    {
        "utterance": "Faranak Fattahi: So yeah, I guess Jay's back, so. ",
        "annotations": {
            "acknowledge contribution": "Faranak acknowledges Jay's return to the meeting."
        }
    },
    {
        "utterance": "Faranak Fattahi: takeaways. ",
        "annotations": {
            "encourage particpation": "Faranak is prompting Jay to share his takeaways since he just returned."
        }
    },
    {
        "utterance": "Emily Balskus: Thanks, Jay. ",
        "annotations": {
            "acknowledge contribution": "Emily acknowledges Jay's return to the meeting after he had stepped away."
        }
    },
    {
        "utterance": "Emily Balskus: Sure, I'm gonna ",
        "annotations": {
            "None": "This utterance is incomplete and does not express a complete thought, hence no code applies."
        }
    },
    {
        "utterance": "Jae Sung: try to summarize all this to ",
        "annotations": {
            "assign_task": "Jae Sung is asked to summarize the key discussion points of the meeting."
        }
    }
]